DIN 02380021 — TOVIAZ 4 MG
TOVIAZ is a tablet (extended-release) of Fesoterodine marketed by PFIZER CANADA ULC. The full Fesoterodine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02380021
- Brand name
- TOVIAZ
- Active ingredient
- Fesoterodine
- Strength
- 4 MG
- Dosage form
- TABLET (EXTENDED-RELEASE)
- Route
- ORAL
- Manufacturer
- PFIZER CANADA ULC
- Health Canada status
- MARKETED
- Drug class
- Antimuscarinic (anticholinergic) agent for overactive bladder
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Fesoterodine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02535998 | ACH-FESOTERODINE | 4 MG | TABLET (EXTENDED-RELEASE) | ACCORD HEALTHCARE INC | MARKETED |
| 02536005 | ACH-FESOTERODINE | 8 MG | TABLET (EXTENDED-RELEASE) | ACCORD HEALTHCARE INC | MARKETED |
| 02521768 | SANDOZ FESOTERODINE FUMARATE | 4 MG | TABLET (EXTENDED-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED |
| 02521776 | SANDOZ FESOTERODINE FUMARATE | 8 MG | TABLET (EXTENDED-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED |
| 02380048 | TOVIAZ | 8 MG | TABLET (EXTENDED-RELEASE) | PFIZER CANADA ULC | MARKETED |